Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hamza Yusuf Dalal"'
Autor:
Hamza Yusuf Dalal, Divya A. Gowda, Anusha, Sharat Damodar, Neha Vyas, Sitalakshmi Subramanian, H Krishnamurthy, V. P. Snijesh
Publikováno v:
Cell Death and Disease, Vol 12, Iss 3, Pp 1-17 (2021)
Cell Death & Disease
Cell Death & Disease
Chronic myeloid leukemia (CML) patients with complex chromosomal translocations as well as non-compliant CML patients often demonstrate short-lived responses and poor outcomes on the current therapeutic regimes using Imatinib and its variants. It has
Autor:
Aditi Shah, Sundareshan T S, K.S. Nataraj, Bharath Ram S, Shilpa Prabhu, Sharat Damodar, Hamza Yusuf Dalal, Shiva Kumar Komaravelli
Publikováno v:
Blood. 136:45-46
Introduction Multiple myeloma (MM) is a malignancy involving terminally differentiated plasma cells. Its incidence in India is about 0.7/1,00,000 population amounting to about 6,800 new cases a year A number of genomic aberrations are associated with
Autor:
Hamza Yusuf Dalal, Shilpa Prabhu, Monisha Harimadhavan, Bharath Ram S, Shiva Kumar Komaravelli, Aditi Shah, Sharat Damodar, Nataraj K S
Publikováno v:
Blood. 136:29-29
INTRODUCTION Acute Graft-versus-host disease (aGVHD) is a common complication of allogeneic hematopoietic cell transplantation (HCT), affecting about 50% of transplants. Grading of aGVHD can serve a variety of purposes, including retrospective assess
Autor:
Mukesh Chawla, Shoba Badiger, Shilpa Prabhu, K.S. Nataraj, Aditi Shah, Bharathram S, Amarnadh Polisetty, Vedam L Ramprasad, Shivakumar Komaravelli, Coral Miriam K, Vidya Veldore, Sunil Bhat, Hamza Yusuf Dalal, Sharat Damodar
Publikováno v:
Blood. 134:5163-5163
BACKGROUND : Clinical Phenotype and outcomes of patients with Acute myeloid leukemia (AML) in the Indian subcontinent differs from published literature. A younger age at diagnosis and higher induction mortality complicate AML management in India(1).
Autor:
Shilpa Prabhu, Sharat Damodar, Hamza Yusuf Dalal, K.S. Nataraj, Amarnadh Polisetty, Devi Prasad Shetty
Publikováno v:
Blood. 134:1073-1073
Heparin-induced thrombocytopenia (HIT) is a drug-induced thrombocytopenia that results in thrombotic complications rather than bleeding.In many countries like India, the availability of functional assay for diagnosing HIT is unavailable. But with the